tak 044 has been researched along with Angiospasm, Intracranial in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Algra, A; Rinkel, GJ; Vergouwen, MD | 1 |
| Macdonald, RL; Nolan, CP; Weyer, GW | 1 |
| Bell, BA; Murray, GD; Pickard, JD; Shaw, MD; Teasdale, GM; Vermeulen, M | 1 |
2 review(s) available for tak 044 and Angiospasm, Intracranial
| Article | Year |
|---|---|
Endothelin receptor antagonists for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update.
Topics: Bosentan; Contraindications; Dioxanes; Endothelin Receptor Antagonists; Humans; Incidence; Peptides, Cyclic; Pyridines; Pyrimidines; Receptors, Endothelin; Subarachnoid Hemorrhage; Sulfonamides; Tetrazoles; Treatment Outcome; Vasospasm, Intracranial | 2012 |
Evidence-based cerebral vasospasm management.
Topics: Evidence-Based Medicine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnesium; MEDLINE; Peptides, Cyclic; Randomized Controlled Trials as Topic; Review Literature as Topic; Subarachnoid Hemorrhage; Vasospasm, Intracranial | 2006 |
1 trial(s) available for tak 044 and Angiospasm, Intracranial
| Article | Year |
|---|---|
Efficacy and safety of the endothelin, receptor antagonist TAK-044 in treating subarachnoid hemorrhage: a report by the Steering Committee on behalf of the UK/Netherlands/Eire TAK-044 Subarachnoid Haemorrhage Study Group.
Topics: Adult; Aged; Brain Ischemia; Double-Blind Method; Endothelin Receptor Antagonists; Female; Follow-Up Studies; Glasgow Outcome Scale; Humans; Male; Middle Aged; Peptides, Cyclic; Receptor, Endothelin A; Receptor, Endothelin B; Subarachnoid Hemorrhage; Survival Rate; Vasospasm, Intracranial | 2000 |